| Bayer (Schweiz) AG - Xarelto vascular 2,5 mg, Filmtabletten | | 66872 | | 01 | | Xarelto vascular 2,5 mg | | Filmtabletten | | B01AF01 | | Rivaroxaban | | 05.04.2019 | | |
| | Composition | | rivaroxabanum 2.5 mg, cellulosum microcristallinum, carmellosum natricum conexum, hypromellosum, lactosum monohydricum 36 mg, magnesii stearas, natrii laurilsulfas, Überzug: hypromellosum, macrogolum 3350, E 171, E 172 (flavum), pro compresso obducto corresp. natrium 0.6 mg. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Rivaroxabanum | 2.5 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Rivaroxabanum | 2.5 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 36 mg | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Pro Compresso Obducto | | |
| |
| |
|
